NCT02748382View on ClinicalTrials.gov

Fluids in Sepsis and Septic Shock

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 18, 2016

Primary Completion Date

August 19, 2017

Study Completion Date

August 19, 2017

Conditions
SepsisSeptic Shock
Interventions
OTHER

higher chloride crystalloid

Normal saline

OTHER

higher chloride albumin

5% Octalbin

OTHER

lower chloride crystalloid

Ringers Lactate

OTHER

lower chloride albumin

5% Plasbumin

Trial Locations (2)

L8V 1C1

Juravinski Hospital-Hamilton Health Sciences, Hamilton

J1H 3H5

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Hamilton Health Sciences Corporation

OTHER

lead

McMaster University

OTHER

NCT02748382 - Fluids in Sepsis and Septic Shock | Biotech Hunter | Biotech Hunter